Several medications are FDA-approved to help people recover from addiction, and the specific drug depends on what substance a person is addicted to. The most well-known are the three medications for opioid addiction (buprenorphine, methadone, and naltrexone), but approved options also exist for alcohol and nicotine dependence. These medications work by reducing cravings, easing withdrawal, or blocking the rewarding effects of the substance.
Medications for Opioid Addiction
Three FDA-approved medications treat opioid use disorder: buprenorphine, methadone, and naltrexone. Each works differently, and the right choice depends on where someone is in their recovery.
Methadone activates the same brain receptors that heroin or prescription painkillers do, but in a slower, more controlled way. Because it fully activates those receptors, it prevents withdrawal symptoms and reduces cravings without producing the intense high of street opioids. People typically receive it daily at a specialized clinic, which can feel restrictive but also provides built-in structure and accountability.
Buprenorphine also activates opioid receptors, but only partially. Think of it as turning the dimmer switch halfway up rather than flipping the light on full blast. This partial activation relieves cravings and withdrawal while carrying a lower risk of dangerous respiratory suppression compared to methadone. Most formulations come as a tablet or film dissolved under the tongue, and doctors can prescribe it from a regular office, making access easier. A newer option, an injectable form given once a month under the skin of the abdomen, removes the need to take a daily dose at all.
Naltrexone takes the opposite approach. Instead of activating opioid receptors, it blocks them entirely. If someone uses opioids while on naltrexone, they feel little to no effect. This removes the reward loop that drives continued use. It comes as a daily pill or a once-monthly injection into the buttock muscle. The critical requirement is that a person must be fully off opioids before starting naltrexone, otherwise it can trigger severe withdrawal.
How Long Treatment Lasts
There is no fixed timeline. Treatment with these medications ranges from months to years, and long-term use is often necessary to prevent relapse. The decision to taper off depends on factors like how well someone is tolerating the medication, whether cravings have subsided, and the stability of their broader recovery. When tapering does happen, it typically takes several months of gradual dose reduction. Stopping abruptly or too early raises the risk of relapse and overdose, because tolerance drops quickly once medication ends.
Medications for Alcohol Addiction
Three FDA-approved medications help people stay sober from alcohol, each targeting a different piece of the puzzle.
Disulfiram was the first, available for over 40 years before any alternative existed. It works through deterrence: if you drink while taking it, your body cannot properly break down alcohol, leading to intense nausea, skin flushing, and a pounding headache. The anticipation of those miserable symptoms helps some people avoid picking up a drink. It does not reduce cravings on its own, so it relies heavily on a person’s motivation and consistency in taking the pill.
Naltrexone, approved for alcohol use in 1994 (and later as a monthly injection in 2006), blocks the receptors in the brain responsible for the pleasurable buzz alcohol produces. Over time, drinking becomes less rewarding, and cravings diminish. This is the same drug used for opioid addiction, just applied to a different substance.
Acamprosate, approved in 2004, works differently. After someone quits drinking, the brain enters a period of hyperexcitability as it adjusts to functioning without alcohol. This shows up as anxiety, restlessness, and insomnia, all of which can drive relapse. Acamprosate calms that overactivity, easing the discomfort of early sobriety. It does not help if someone is still actively drinking; it is specifically designed to support abstinence once it has already begun.
Medications for Nicotine Addiction
Nicotine replacement therapy (patches, gum, lozenges) is the most familiar option, but two prescription medications outperform it.
Varenicline is the most effective first-line medication for quitting smoking. It latches onto the same receptors in the brain that nicotine does, providing a mild release of dopamine that takes the edge off cravings. At the same time, it blocks nicotine from fully activating those receptors, so if you do smoke a cigarette, it feels less satisfying. Clinical trials show that varenicline leads to higher rates of sustained abstinence at one year compared to other treatments, and it also does a better job of preventing relapse.
Bupropion, originally developed as an antidepressant, helps by boosting dopamine and norepinephrine levels in the brain. This partially compensates for the chemical drop-off that makes quitting so uncomfortable. It reduces cravings and blunts the anger, restlessness, and difficulty concentrating that come with nicotine withdrawal. Both medications can cause side effects like nausea, insomnia, and vivid dreams, but these are generally manageable and tend to ease over time.
Naloxone: The Emergency Overdose Drug
Naloxone is not a treatment for addiction itself, but it is the drug most commonly associated with saving lives during an opioid overdose. It works by rapidly knocking opioids off the brain’s receptors, reversing the dangerous slowing of breathing that causes overdose deaths. It is available as a nasal spray or injection and can be used by bystanders with no medical training.
One important limitation: naloxone wears off faster than most opioids do. Its effects last roughly 30 to 90 minutes, which means a person can slip back into overdose after the naloxone fades. Multiple doses are sometimes needed, and anyone who receives naloxone still needs emergency medical attention.
Stimulant Addiction: A Gap in Treatment
For stimulants like methamphetamine and cocaine, no medication currently has FDA approval. This is one of the biggest unmet needs in addiction medicine. The combination showing the most promise in clinical research is bupropion (the same antidepressant used for nicotine) paired with naltrexone. Several other drugs are being studied in clinical trials, but nothing has crossed the threshold for approval yet. Treatment for stimulant addiction currently relies primarily on behavioral therapy and counseling.
Why Medication Alone Isn’t the Full Picture
Medication handles the biological side of addiction: the cravings, the withdrawal, the hijacked reward system. But addiction also involves habits, triggers, relationships, and often co-occurring mental health conditions like depression or trauma. Medication works best when combined with some form of counseling or behavioral support. The medication stabilizes brain chemistry enough for a person to actually engage in the psychological work of recovery, rather than white-knuckling through constant cravings while trying to rebuild their life.